证券日报网讯11月12日晚间，传音控股发布公告称，公司董事会同意提名黄绮汶女士为公司第三届董事 会独立董事候选人。 ...

Core Viewpoint - Transsion Holdings plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its competitiveness and international brand image while diversifying its financing channels [1][2] Group 1: Company Overview - Transsion Holdings is recognized as the "King of African Mobile Phones" and has established manufacturing centers in Ethiopia, India, and Bangladesh, with products available in over 70 countries [1] - As of November 12, the stock price of Transsion Holdings was 65.85 CNY per share, with a total market capitalization of 758 billion CNY [3] Group 2: Financial Performance - In the first three quarters of the year, Transsion Holdings reported revenue of 49.54 billion CNY, a year-on-year decline of 3.33%, and a net profit of 2.148 billion CNY, down 44.97% [1] - In the third quarter, revenue increased by 22.6% year-on-year, while net profit decreased by 11.06% [1] Group 3: Market Position and Strategy - Transsion Holdings holds a global smartphone market share of 8.6%, ranking fourth overall, and leads in smartphone shipments in Africa, Pakistan, Bangladesh, and the Philippines [1] - The company plans to adjust its pricing and product structure in response to market competition and supply chain costs to maintain healthy gross margins [2] - The H-share issuance and listing require approval from the company's shareholders and relevant regulatory bodies, including the China Securities Regulatory Commission and the Hong Kong Stock Exchange [2] Group 4: Industry Trends - The trend of Chinese consumer electronics companies listing in Hong Kong is growing, with several companies like Lens Technology and Luxshare Precision already initiating their listing processes [3] - Industry experts suggest that companies with global production capabilities and localized operations will have a competitive edge, making the Hong Kong listing a crucial strategy for deepening global expansion [3]

点击查看公告原文>> 责任编辑：小浪快报 深圳传音控股股份有限公司（证券代码：688036）于2025年11月13日发布公告称，公司已于2025年11月 12日召开第三届董事会第二十次会议，审议通过了发行H股股票并在香港联合交易所有限公司主板上市 的相关议案，本次发行上市尚需提交公司股东会审议，并需取得中国证券监督管理委员会、香港联交所 及香港证券及期货事务监察委员会等监管机构的备案、批准和/或核准；公司本次筹划香港上市旨在进 一步提高综合竞争力，提升国际品牌形象，更好地利用国际资本市场以多元化融资渠道，计划在股东会 决议有效期内（自审议通过之日起24个月或同意延长的其他期限）选择适当时机完成发行；截至公告披 露日，公司正积极与相关中介机构商讨本次发行的具体工作，除董事会已审议通过的议案外，其他关于 本次发行H股并上市的具体细节尚未确定。 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验 ...

Group 1 - Peking University Medicine's chairman Xu Xiren has been arrested for criminal charges, but the company's control remains unchanged and operations are normal [3] - Victory Shares plans to issue shares and pay cash to acquire assets, along with raising supporting funds, following a significant stock price fluctuation [4] - Bangji Technology has terminated a major asset restructuring due to failure to reach an agreement with the counterparty, after experiencing a significant stock price decline [5] Group 2 - ST Songfa has completed a major asset restructuring, changing its main business from ceramics to shipbuilding and high-end equipment [6] - Oriental Yuhong plans to sell certain properties, expecting to incur an asset disposal loss of 25.81 million yuan, which exceeds 10% of its audited net profit [7] - Baili Tianheng has decided to delay its global issuance and listing of H-shares due to current market conditions [8] Group 3 - Transsion Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its competitiveness and international brand image [9] - Shengtun Mining intends to invest approximately 1.423 billion yuan in its wholly-owned subsidiary Shengtun Gold International [11] - Haibo Sichuang has signed a strategic cooperation agreement with CATL, committing to a cumulative procurement of no less than 200 GWh of electricity from 2026 to 2028 [12] Group 4 - Century Huatong plans to repurchase shares worth between 500 million and 1 billion yuan, with a maximum repurchase price of 28.77 yuan per share [14] - Shannon Chip Innovation's major shareholder has reduced its stake by 549,200 shares, bringing its holding below 5% [16] - Fangzheng Electric's shareholder Zhang Min has reduced his stake by 1.6324 million shares, now holding 5% of the total shares [17] Group 5 - Longjian Co. has won a project worth 483 million yuan for road maintenance in Heilongjiang Province [21][22] - Zhejiang Communications has been awarded a project estimated at 11.103 billion yuan for new urbanization construction in Tonglu County [23] - Dash Smart has secured a project for the intelligent construction of the new Huanggang Port, with a contract value of 55.06 million yuan [24]

Group 1 - Longjian Co., Ltd. won a bid for a highway maintenance project in Heilongjiang with a contract value of 483 million yuan, accounting for 2.64% of the company's expected revenue for 2024 [1] - Transsion Holdings plans to issue H-shares and list on the main board of the Hong Kong Stock Exchange [1] - Good Home's controlling shareholder intends to reduce its stake by up to 2.7%, equivalent to no more than 39.4468 million shares [1][2] Group 2 - Xinhua Insurance reported a cumulative premium income of 181.973 billion yuan from January to October, representing a year-on-year growth of 17% [2][4] - Zhejiang Jiaokao is part of a consortium that plans to bid for a new urbanization project with an estimated total investment of 11.103 billion yuan [4] Group 3 - Changchun High-tech received approval for clinical trials of a vaccine for adolescents and adults [6] - XinNuoWei's application for the listing of Pertuzumab injection has been accepted, targeting HER2-positive breast cancer [8] - Dash Smart won a bid for an intelligent project at the new Huanggang Port inspection building, valued at 55.056 million yuan, which is 1.74% of its expected revenue for 2024 [8] Group 4 - Electronic City is involved in a lawsuit for debt recovery, with the amount in dispute estimated at 777 million yuan [9] - Haibo Technology signed a strategic cooperation agreement with CATL for a cumulative procurement of no less than 200 GWh of electricity from 2026 to 2028 [10] Group 5 - Renfu Pharmaceutical's HW231019 tablets have entered the second phase of clinical trials for postoperative pain relief [11] - Tonghua Dongbao received a drug registration certificate for Aspart Insulin injection from the Dominican Republic [11] Group 6 - Shaanxi Construction reported winning major projects worth a total of 1.016 billion yuan in October [12] - Fuzhou Environmental Protection plans to change its stock name to "Fuzhou Technology" [12] Group 7 - Panlong Pharmaceutical's gel patch for knee osteoarthritis has received approval for clinical trials [15] - Zhongyida's application for a specific stock issuance has been terminated by the Shanghai Stock Exchange [16] Group 8 - Zhizhong Home's controlling shareholder reduced its holdings of convertible bonds by 905,000 units, accounting for 13.51% of the total issued [19] - Haibo Co., Ltd. plans to establish a subsidiary with an investment of 1 billion yuan for high-end component projects [21] Group 9 - Caina Co. plans to use 57 million yuan of idle funds to purchase structured deposits [23] - Zhendong Pharmaceutical's new drug for acute ischemic stroke has entered the IIa phase of clinical trials [25] Group 10 - Weiman Sealing's overseas subsidiary plans to lease a factory in Saudi Arabia for 5 years at a total rent of approximately 54.039 million yuan [26] - Yiling Pharmaceutical's application for Memantine Hydrochloride has been approved for market entry [28] Group 11 - Dongfang Zhizao plans to acquire 70% of Saifu Machinery for 27.4887 million yuan [30] - JianKai Technology's actual controller intends to transfer 3% of the company's shares through inquiry [31] Group 12 - Rejing Bio plans to repurchase shares worth between 100 million and 200 million yuan [32] - Bangji Technology has decided to terminate a major asset restructuring project due to failure to reach an agreement [34] Group 13 - Huadong Pharmaceutical's application for the marketing license of a new drug has been accepted [36] - Zhonggu Logistics' shareholder plans to reduce its stake by up to 3% [38] Group 14 - Bohui Innovation's subsidiary received approval for a clinical trial of a vaccine for invasive infections [40] - Shannon Chip's shareholder pledged 0.27% of the company's shares for financing [42] Group 15 - Shanghai Petrochemical appointed a new general manager [44] - Jiaojian Co. plans to reduce the holdings of some directors and executives by up to 0.35% [46] Group 16 - Weiting Electric plans to raise no more than 300 million yuan through a private placement [47] - Zhongjin Irradiation plans to invest approximately 200 million yuan in an electronic accelerator manufacturing project [49] Group 17 - Tongxing Technology signed a framework agreement to invest 3.2 billion yuan in a sodium battery project [50] - Hongri Da plans to establish a subsidiary focused on semiconductor packaging [51] Group 18 - Shanghai Kaibao's new drug for acute ischemic stroke has received approval for clinical trials [53] - Yitong Century announced a change in its control structure, becoming a company without a controlling shareholder [55]

| | | 投资者关系管理制度（草案） 第一章 总则 第二章 投资者关系工作的目的和原则 2 第一条 为进一步加强公司与投资者和潜在投资者（以下合称"投资者"）之间的 信息沟通，加深投资者对公司的了解和认同，促进公司与投资者之间的 良性关系，在投资公众中建立公司的诚信度，提升公司的投资价值，以 利于完善公司治理结构，提高公司的核心竞争力，实现公司价值最大化 和股东利益最大化，以切实保护投资者利益，根据《中华人民共和国公 司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下 简称"《证券法》"）、《上市公司投资者关系管理工作指引》《上海证 券交易所科创板股票上市规则》《深圳传音控股股份有限公司信息披露 制度》《香港联合交易所有限公司证券上市规则》（以下简称"《香港联 交所上市规则》"）及其它有关法律、法规和《公司章程》，结合本公司 实际情况，特制定本制度。 第二条 投资者关系是指公司与公司的股权、债权投资者或潜在投资者之间的关 系。投资者关系管理工作是指公司通过便利股东权利行使、信息披露、 互动交流和诉求处理等工作，加强与投资者及潜在投资者之间的沟通， 增进投资者对公司的了解和认同，以提升公司治理水 ...

| | | 内部审计管理制度（草案） 第一章 总则 （一）遵守国家法律、法规、公司股票上市地证券监管规则、规章及其 他相关规定； （二）提高公司经营的效率与效果； （三）保障公司资产的安全； （四）确保公司信息披露的真实、准确、完整和公平。 第四条 公司依照国家有关法律、法规、公司股票上市地证券监管规则、规章、 规范性文件及本制度的规定，结合本公司所处行业和生产经营特点，建 立健全内部审计制度，防范和控制公司风险，增强公司信息披露的可靠 性。 （六）协调内部审计机构与外部审计机构等外部审计单位之间的关系。 公司内部审计部门须向审计委员会报告工作。内部审计部门提交给管理 层的各类审计报告、审计问题的整改计划和整改情况须同时报送审计委 员会。内部审计机构发现相关重大问题或者线索，应当立即向审计委员 会直接报告。 公司董事会应当对内部控制制度的建立健全和有效实施负责，重要的内 部控制制度应当经董事会审议通过。公司董事会及其全体成员应当保证 内部控制相关信息披露内容的真实、准确、完整。 本制度适用于公司及公司所有全资子公司和控股子公司及其控股、控制 的所有关联企业（以下简称"子公司"）。 第二章 内部审计机构和人员 ...

| 第一章 | 总则 | 2 | | --- | --- | --- | | 第二章 | 组织管理 | 2 | | 第三章 | 财务管理 | 4 | | 第四章 | 经营及投资决策管理 | 5 | | 第五章 | 利润分配原则 | 6 | | 第六章 | 人事、薪酬及福利管理 | 7 | | 第七章 | 信息披露 | 7 | | 第八章 | 监督审计 | 8 | | 第九章 | 考核与奖罚 | 9 | | 第十章 | 附则 | 9 | 第一章 总则 第二章 组织管理 第八条 本公司按照子公司章程规定向子公司委派或推荐董事、监事、高级 管理人员及其他管理人员(以下合称"公司派出人员")。 第九条 子公司担任董事、监事及高级管理人员的人选必须符合《公司法》、 《公司章程》和各子公司章程关于董事、监事及高级管理人员任职 条件的规定。有《公司法》第一百七十八条规定情形之一的，不得 担任子公司的董事、监事、高级管理人员。 第十条 子公司的董事、监事、高级管理人员具有以下职责： (一) 依法行使董事、监事、高级管理人员义务，承担董事、监事、 高级管理人员责任； (二) 督促子公司认真遵守国家有关法律、法规规定、公司股票上 ...

证券代码：688036 证券简称：传音控股 公告编号:2025-038 深圳传音控股股份有限公司 关于聘请 H 股发行并上市审计机构的公告 天健国际成立于 2016 年，是一所根据香港法律设立的合伙制事务所，属于 天健会计师事务所(特殊普通合伙)的国际网络成员所，为众多香港上市公司提供 审计服务，包括工业生产、食品加工、医药制造、物业投资、汽车生产及证券商 等多个行业。 天健国际的注册地址为香港湾仔庄士敦道 181 号大有大厦 1501-8 室。 天健国际根据香港《会计及财务汇报局条例》注册为公众利益实体核数师。 此外，天健国际经中华人民共和国财政部批准取得在中国内地临时执业审计业务 许可证。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 拟聘请H股发行并上市审计机构：天健国际会计师事务所有限公司 深圳传音控股股份有限公司（以下简称"公司"）于 2025 年 11 月 12 日召开 第三届董事会第二十次会议及第三届监事会第十六次会议，审议通过了《关于公 司聘请 H 股发行并上市的审计机构的议案》，同意公司 ...

深圳传音控股股份有限公司 独立董事候选人声明与承诺 本人黄绮汶，已充分了解并同意由提名人深圳市传音投资有限公司提名为深 圳传音控股股份有限公司第三届董事会独立董事候选人。本人公开声明，本人具 备独立董事任职资格，保证不存在任何影响本人担任深圳传音控股股份有限公司 独立董事独立性的关系，具体声明并承诺如下： 一、本人具备上市公司运作的基本知识，熟悉相关法律、行政法规、部门规 章及其他规范性文件，具有五年以上法律、经济会计、财务、管理等履行独立董 事职责所必需的工作经验。 二、本人任职资格符合下列法律、行政法规和部门规章以及公司规章的要求： （一）《中华人民共和国公司法》等关于董事任职资格的规定； （二）《中华人民共和国公务员法》关于公务员兼任职务的规定（如适用）； （三）中国证监会《上市公司独立董事管理办法》和上海证券交易所自律监 管规则有关独立董事任职资格和条件的相关规定； （四）中共中央纪委、中共中央组织部《关于规范中管干部辞去公职或者退 （离）休后担任上市公司、基金管理公司独立董事、独立监事的通知》的规定（如 适用）； （五）中共中央组织部《关于进一步规范党政领导干部在企业兼职（任职） 问题的意见》的相关 ...